H5N1 Researcher Continues Legal Battle

The Dutch scientist who mutated a strain of the avian flu virus to be transmissible between mammals is headed to appeals court to protect his right to publish the work unimpeded.

By | November 6, 2013

Avian influenza A H5N1 viruses (gold)WIKIMEDIA, CDC/COURTESY OF CYNTHIA GOLDSMITH; JACQUELINE KATZ; SHERIF R. ZAKIThe legal battle between Ron Fouchier and the Dutch government is dragging on, with the scientist’s employer, Erasmus Medical Center in Rotterdam, appealing the September district court decision that legitimized the government’s requirement that Fouchier obtain an export license to publish his work. At issue is the potential for Fouchier’s research, which involves mutating H5N1 avain flu to become transmissible between ferrets, to be used by bioterrorists.

Fouchier published his initial report on the work in a June 2012 issue of Science, but only after obtaining an export license from the Dutch government under protest. Prior to the publication, a US biosecurity panel suggested that some of the results in Fouchier’s paper and a similar study from a group at the University of Wisconsin, Madison, should be redacted to guard against misuse of the information for nefarious purposes. This recommendation sparked a worldwide moratorium on such research, but the panel later reversed course and greenlighted the full publication of the work. In April 2012, Fouchier told Nature that he would “never apply for an export permit on a scientific manuscript for publication in a journal. We do not want to create a precedent here. We might end up in court indeed if they insist on censorship.”

Court is exactly where Fouchier ended up after Erasmus MC challenged the government’s insistence that the researcher obtain an export license to publish the paper. But a Dutch district court in Haarlem ruled that the government was well within its rights to require that Fouchier secure such a license, which the researcher and many in the scientific community viewed as an attack on academic freedom.

With Erasmus MC appealing that decision, the case now moves on to Court of Appeal in Amsterdam. Meanwhile, the European Society for Virology (ESV) is throwing its support behind Fouchier. ESV President Giorgio Palù recently wrote a letter to European Commission President José Manuel Barroso voicing his concern, according to ScienceInsider. “This Dutch ruling may have far-stretching implications for research and public and animal health within all EU Member States,” he wrote.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: dr.mp.mph

dr.mp.mph

Posts: 21

November 11, 2013

Interesting, but the trouble is that when we have freedom, if we don't regulate ourselves, someone will step in and do that for us. All knowledge is valuable, but it can be naïve to ignore one set of consequences over another.

I would hate to see research censored and restricted, but on the other hand...

I need to learn the aims of the original paper before I say more. It sounds a little unreasonable to intentionally make a dangerous virus capable of infecting a species that is kept as a pet.

(Conversely, studying a mammalian system could help us treat it in humans. How good of a model is the ferret, I wonder?)

Avatar of: dr.mp.mph

dr.mp.mph

Posts: 21

November 11, 2013

As far as the article, it would have been nice if a few more details were given about an export license. What would be the fate of the research? Would the information be restricted to the country of origin?

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Rainin Instrument
Rainin Instrument
Advertisement
Life Technologies